| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Stout Jay S | Chief Technology Officer | C/O IMMUNOVANT, INC., 320 W 37TH STREET, 6TH FLOOR, NEW YORK | /s/ Tiago Girao, attorney-in-fact for Jay Stout | 09 Jan 2026 | 0001702969 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IMVT | Common Stock | Sale | $30,433 | -1,148 | -0.57% | $26.51 | 199,666 | 07 Jan 2026 | Direct | F1, F2 |
| transaction | IMVT | Common Stock | Sale | $1,481 | -55 | -0.03% | $26.92 | 199,611 | 07 Jan 2026 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | On April 2, 2024, the holder was granted 54,978 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 4, 2024, of which 3,436 of these RSUs vested on January 2, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. |
| F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.90 - $26.89 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| F3 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.91 - $26.94 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |